Scarica l'app Stockscreener
3.43
1.48%
0.05
Dopo l'orario di chiusura:
3.35
-0.08
-2.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.38
Aprire:
$3.39
Volume 24 ore:
221.26K
Relative Volume:
1.02
Capitalizzazione di mercato:
$136.52M
Reddito:
$2.00M
Utile/perdita netta:
$43.81M
Rapporto P/E:
3.4208
EPS:
1.0027
Flusso di cassa netto:
$-11.03M
1 W Prestazione:
+4.41%
1M Prestazione:
+5.54%
6M Prestazione:
+42.32%
1 anno Prestazione:
+43.51%
Intervallo 1D:
$3.3501
$3.58
Intervallo di 1 settimana:
$3.152
$3.58
Portata 52W:
$1.82
$3.76
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.43 | 136.52M | 2.00M | 43.81M | -11.03M | 1.0027 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Lifeward shareholders approve Oramed partnership deal - Investing.com India
Lifeward shareholders approve Oramed partnership deal By Investing.com - Investing.com Australia
Lifeward Partners with Oramed to Enhance Biotech Portfolio and Drive Path to Profitability - Quiver Quantitative
Shareholders back Lifeward–Oramed bet on insulin pills and $47M war chest - Stock Titan
Gains Report: What is the target price for Oramed Pharmaceuticals Inc stockChart Signals & Consistent Return Investment Signals - baoquankhu1.vn
Aug PreEarnings: What is Oramed Pharmaceuticals Incs 5 year growth outlookWeekly Profit Recap & Expert Curated Trade Setups - baoquankhu1.vn
Oramed Pharmaceuticals (ORMP) Leads Healthcare Dividend Yields - GuruFocus
Top 10 healthcare stocks with highest dividend yield amid volatile markets (ORMP:NASDAQ) - Seeking Alpha
Dip Buying: Is Oramed Pharmaceuticals Inc stock a smart retirement pick2025 Growth vs Value & Safe Entry Trade Signal Reports - baoquankhu1.vn
Update Report: Can Oramed Pharmaceuticals Inc maintain sales growthShare Buyback & Accurate Buy Signal Alerts - baoquankhu1.vn
ORMP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Interest in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Declines By 16.2% - MarketBeat
ORMP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ORMP Technical Analysis & Stock Price Forecast - Intellectia AI
Guidance Update: Should you avoid Oramed Pharmaceuticals Inc stock right nowJuly 2025 Breakouts & Low Drawdown Investment Strategies - baoquankhu1.vn
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Passes Above 50 Day Moving AverageHere's Why - MarketBeat
Scilex Grants Oramed New Warrant in Financing Agreement - The Globe and Mail
Is Oramed Pharmaceuticals Inc. stock overvalued or fairly priced2025 Earnings Impact & Weekly Stock Breakout Alerts - mfd.ru
Oramed Pharmaceuticals Restructures Scilex Notes via Warrant Deal - TipRanks
Oramed (NASDAQ: ORMP) gains Scilex stock warrant through new agreement - Stock Titan
What is the target price for Oramed Pharmaceuticals Inc. stockEarnings Risk Report & Low Risk High Win Rate Stock Picks - mfd.ru
Is Oramed Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Trade Ideas & AI Driven Price Predictions - mfd.ru
ORMP PE Ratio & Valuation, Is ORMP Overvalued - Intellectia AI
What are analysts’ price targets for Oramed Pharmaceuticals Inc.Quarterly Earnings Summary & Daily Entry Point Trade Alerts - mfd.ru
Will Oramed Pharmaceuticals Inc. (OJU1) stock recover faster than industryJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Aug Setups: What drives Oramed Pharmaceuticals Inc.’s stock priceJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January - MarketBeat
ORMP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Geopolitics Watch: Can Oramed Pharmaceuticals Inc keep up with sector leaders2025 Earnings Surprises & Weekly Top Gainers Trade List - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc. stock undervalued right nowMarket Volume Summary & AI Powered Market Trend Analysis - mfd.ru
Support Test: Should you avoid Oramed Pharmaceuticals Inc stock right now2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Will Oramed Pharmaceuticals Inc. (OJU1) stock test record highs in 2025Weekly Earnings Recap & Reliable Momentum Entry Alerts - mfd.ru
Can Oramed Pharmaceuticals Inc. maintain sales growthJuly 2025 Levels & Real-Time Stock Price Movement Reports - mfd.ru
What drives Oramed Pharmaceuticals Inc.’s stock priceDividend Hike & Accurate Trade Setup Notifications - mfd.ru
What hedge funds are buying Oramed Pharmaceuticals Inc.2025 Winners & Losers & Verified Momentum Stock Alerts - mfd.ru
Lifeward Ltd. announced that it has received $0.525 million in funding - marketscreener.com
Bull Bear: What is the target price for Oramed Pharmaceuticals Inc. stockSwing Trade & Intraday High Probability Alerts - mfd.ru
NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN
Oramed Pharmaceuticals (NASDAQ:ORMP) & Demant A/S (OTCMKTS:WILYY) Head to Head Analysis - Defense World
Pullback Watch: Is Oramed Pharmaceuticals Inc stock a smart retirement pickQuarterly Profit Report & Daily Technical Forecast Reports - baoquankhu1.vn
What is the next catalyst for Oramed Pharmaceuticals Inc.July 2025 Sentiment & Stock Portfolio Risk Control - mfd.ru
Swing Trade: What is Oramed Pharmaceuticals Incs 5 year growth outlookJuly 2025 Market Mood & Breakout Confirmation Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals Achieves 60.85% Return, Leading Market Performance - Markets Mojo
OraTech to pioneer oral insulin with $75 million investment - MSN
Oramed Pharm completes warrant sale, boosting liquidity - MSN
NNDM Stock In Focus: Nano Dimension Pops A Poison Pill Days After Oramed Stake Build-Up - Asianet Newsable
Aug Update: What is ReTo Eco Solutions Incs book value per shareJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals Inc Intends to Engage Nano Dimension Ltd - marketscreener.com
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Jobs Data: Is Oramed Pharmaceuticals Inc stock good for income investors2025 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Oramed Shares Face Pressure Amid Strategic Pivot and Dividend Focus - AD HOC NEWS
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):